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Michael addition reaction to produce the PLA-GLU and PLA-ASP
conjugate1. Peptide conjugation was characterized via AFM, FTIR
and XPS. Next, hMSCs are seeded on the surface modified NF and
cultured in osteogenic media for 28 days. Differentiation of MSCs
was evaluated by measuring the alkaline phosphatase activity, aliz-
arin red staining, total calcium content, gene expression levels and
immunofluorescence staining of osteogenic markers of collagen type
I, osteocalcin and osteopontin. Surface characterization of PLA-GLU
and PLA-ASP successfully confirms peptide conjugation on NF and
osteogenic differentiation of hMSC on surface modified NF are un-
derway. The outcomes of this study would help to determine the most
effective sequence on hMSCs on osteogenic differentiation for fur-
ther modification of the synthetic scaffolds.
1. Karaman O. et al, J Tissue Eng Regen Med, 10(2): p. E132-
46(2016).
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Mechanically Tuned Aligned Nanofibers and GDNF to Improve
Nerve Growth Conduits
T. J. Whitehead1, E. A. Mays1, J. Peduzzi2, A. Mazhari3, C. Chen1,
J. M. Cavanaugh1, H. G. Sundararagahavan1;
1Biomedical Engineering, Wayne State University, Detroit, MI,
2Anatomy and Cell Biology, Wayne State University, Detroit, MI,
3Neurosurgery, Wayne State University, Detroit, MI.
Treatments for peripheral nerve injury includes autografts and
nerve growth conduits (NGC). This project enhances existing NGCs
by incorporating aligned nanofibers (topographical) made from a
compliant substrate (mechanical) with growth factor (GF) releasing
microspheres (chemical). We hypothesize that these cues along with
physical therapy (PT) will result in enhanced function recovery.
Polycaprolactone conduits with longitudinally alignedmethacrylated
hyaluronic acid fibers, with or without microspheres containing glial
cell line-derived neurotrophic factor were tested in rat sciatic nerves.
The animals were divided into five groups: fibers, fibers + PT, fibers +
GF, fibers + GF + PT, and autograft control. All animals received
behavior and functional testing prior to surgery and weekly post-
surgery for 60 days. Prior to sacrifice the Compound Muscle Action
Potentials (CMAP) of the gastrocnemius muscles were measured.
Gastrocnemius muscles and sciatic nerves were harvested for his-
tological analysis. All surgical procedures and animal testing was
approved by the Wayne State University Institutional Animal Care
and Use Committee. Weekly testing showed that fibers with GF
enhanced or accelerated functional recovery. By 4 weeks both the GF
groups were performing similarly to the autograft in the footfall test.
Interestingly, starting at week 5, the fibers + PT group was also near
autograft. Von Frey fibers were used to test the sensory perception.
This study indicates that GFs combined with aligned fibers can im-
prove functional recovery following peripheral nerve injury and that
physical therapy can have a positive effect, though it may not have an
additive effect when combined with GFs.
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Development of an Elastic and Adhesive Sealant
for Surgical Applications
N. Annabi1,2,3, Y. Zhang2,3, A. Assmann2,3,4, E. Shirzaei Sani1,
A. Vegh2,3, G. Cheng2, B. Dehghani2, G. U. Ruiz-Esparza2,
X. Wang2, A. S. Lassaletta, 021155, S. Gangadharan5, A. S. Weiss6,
A. Khademhosseini2,3;
1Chemical Engineering, Northeastern University, Boston, MA,
2Biomaterials Innovation Research Center, Harvard Medical School,
Cambridge, MA, 3Massachusetts Institute of Technology,
Cambridge, MA, 4Harvard University, Cambridge, MA, 5Beth Israel
Deaconess Medical Center, Boston, MA, 6University of Sydney,
NSW, AUSTRALIA.
Conventional surgical sealants have been used for sealing or re-
pairing defects often suffer from low adhesion strength, insufficient
mechanical stability and strength, cytotoxic degradation products,
and weak performance in biological environments. Therefore, in this
study we aimed to engineer a photocrosslinked and highly biocom-
patible sealant with tunable mechanical and adhesion properties us-
ing tropoelastin, as a genetically modified human protein. We tuned
the degree of methacrylation of tropoelastin and prepolymer con-
centration to optimize the physical properties and adhesion strength
of the methacryloyl-substituted tropoelastin (MeTro) hydrogel for
sealing of elastic and soft tissues. Following ASTM standard tests,
the MeTro hydrogels revealed superior adhesive strength and burst
pressure values compared to the commercially available sealants.
The subcutaneous implantation of the engineered MeTro hydrogels
in rats exhibited minimal inflammatory host responses and slow
biodegradation of sealant. The in vivo and ex vivo burst pressure
resistance of bioengineered MeTro sealants was tested on lungs and
arteries in small as well as translational large animal models. Our
results proved MeTro sealant to effectively seal lung and artery
leakages without the need for sutures or staples, presenting a sig-
nificant improvement compared to the commercially available clin-
ical sealants (Evicel and ProgelTM) and sutures only. Combining
these results, we envision that the engineered MeTro sealant has the
potential to be commercialized due to its remarkable mechanical
strength, biocompatibility, biodegradability and strong adhesive in-
teraction between the sealant and the wound tissue without the need
for suturing.
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Seeding and Recellularization of Porcine Acellular Muscle
Matrix Biomaterials with Adipose-Derived Mesenchymal
Stem Cells and C2C12 Myoblasts
J. N. Schroen, C. T. Pham, T. D. Collins, N. N. Mseis, A. van Eldik,
C. E. Burt, M. M. Stern;
Biology, Winthrop University, Rock Hill, SC.
The ability of skeletal muscle to repair itself via regenerative
mechanisms is limited to instances where tissue damage is relatively
small. When volumetric muscle loss occurs, the regenerative ca-
pacity of skeletal muscle is exceeded. This results in a permanent loss
of muscle volume and function. Current strategies to replace or repair
such damage are inadequate. The goal of this project is to develop
natural biomaterials that facilitate the engineering and/or regenera-
tion of skeletal muscle tissue by providing a myoinductive envi-
ronment to seeded and/or infiltrating cells. We hypothesized that
scaffolds and hydrogels composed of porcine acellular muscle matrix
(PAMM) could be efficiently recellularized and support myogenic
differentiation. Here, we describe the production and characteriza-
tion of PAMM scaffolds and gels. Histological analyses, DNA
content measurement, and scanning electron microscopy show that
porcine skeletal muscle tissue can be effectively decellularized and
processed into both a sheet-like scaffold and a hydrogel. We also
demonstrate that PAMM biomaterials can be recellularized with
adipose-derived mesenchymal stem cells and support the differen-
tiation of C2C12 myoblasts into myotubes. These results demonstrate
the potential for PAMM biomaterials to be employed in tissue en-
gineering and regenerative medicine-based strategies for repairing
volumetric muscle loss.
Cardiovascular
494
Bioprinting of Engineered Heart Tissue
P. Koti1, N. Muselimyan1, B. Holmes1,2, H. Asfour1, N. Sarvazyan1;
1Pharmacology and Physiology, The GeorgeWashington University,
Washington, DC, 2Nanochon LLC, Burke, VA.
For cardiac tissue repair, 3D bioprinting holds great potential
enabling to create multicellular constructs with defined shape and
cell composition. However, materials selection and effective struc-
tures that can be reliably used to bioprint cardiac tissue constructs
remain elusive. Here we present a concerted effort to fine tune
POSTER ABSTRACTS S-123
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